Labeling autologous leukocytes with indium-111 oxine

Area of Science:

• Nuclear Medicine
• Radiopharmacology
• Immunology

Background:

• Inflammatory processes and abscesses require accurate localization for effective treatment.
• Current diagnostic methods may have limitations in specificity and timely detection.
• Autologous leukocyte imaging offers a targeted approach to identify sites of inflammation.

Purpose of the Study:

• To describe a method for labeling autologous leukocytes with indium-111 oxine.
• To evaluate the efficacy of indium-111-labeled leukocytes for localizing inflammatory processes, specifically abscesses.
• To highlight the advantages of using indium-111 for diagnostic imaging.

Main Methods:

• Preparation of indium-111 oxine by chelating indium-111 chloride with oxine.
• Isolation and labeling of autologous leukocytes using the prepared indium-111 oxine solution.
• Extraction, purification, and dilution of the radiolabeled complex in saline for cell suspension.

Main Results:

• Indium-111-labeled leukocytes demonstrated high specificity in localizing abscesses in clinical studies.
• Indium-111's gamma emissions are suitable for external detection, facilitating imaging.
• The 67-hour half-life of indium-111 allows for extended study periods with acceptable radiation doses.

Conclusions:

• The described method provides a reliable way to label autologous leukocytes with indium-111 oxine.
• Indium-111-labeled leukocyte imaging is a valuable tool for specific abscess localization.
• This technique enhances diagnostic capabilities for inflammatory conditions.